| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/17/2009 | WO2009113660A1 Microorganism producing cyclic compound |
| 09/17/2009 | WO2009113649A1 Antibody having an immune-enhancement function |
| 09/17/2009 | WO2009113628A1 Method of denaturing protein with enzymes |
| 09/17/2009 | WO2008041863A9 Novel genes and polypeptides associated with insecticidal activity |
| 09/17/2009 | WO2005072129A9 Production of host cells containing mutiple integrating vectors by serial transduction |
| 09/17/2009 | US20090234101 Directed evolution of novel binding proteins |
| 09/17/2009 | US20090233993 Compositions and methods for inhibiting gsk3 activity and uses thereof |
| 09/17/2009 | US20090233870 Antimicrobial Peptides |
| 09/17/2009 | US20090233855 Compounds and methods for modulating activation of nf-kb |
| 09/17/2009 | US20090233850 CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions |
| 09/17/2009 | US20090233849 Recombinant Alpha-Fetoprotein, Method and Means for Preparation Thereof, Compositions on the Base Thereof and Use Thereof |
| 09/17/2009 | US20090233379 Taste Receptors Of The T1R Family From Domestic Dog |
| 09/17/2009 | US20090233343 Affinity purification of protein |
| 09/17/2009 | US20090233334 Cell cultivation and production of recombinant proteins by means of an orbital shake bioreactor system with disposable bags at the 1,500 liter scale |
| 09/17/2009 | US20090233333 Methods for preventing gluconoylation of proteins |
| 09/17/2009 | US20090233332 Method of producing recombinant protein |
| 09/17/2009 | US20090233311 receptor binding assay; analysis and determining the level of procalcitonin in blood wherein an increased level of procalcitonin compared to healthy individuals is indicative of sepsis |
| 09/17/2009 | US20090233290 Mutant SepRS, and method for site-specific introduction of phosphoserine into protein using the same |
| 09/17/2009 | US20090233283 Stable compositions for nucleic acid amplification and sequencing |
| 09/17/2009 | US20090232842 HPV Vaccine Comprising Peptides From Host Cell Proteins |
| 09/17/2009 | US20090232830 Modified HIV-1 Envelope Proteins |
| 09/17/2009 | US20090232823 Anti-tyrp1 antibodies |
| 09/17/2009 | US20090232820 Neisseria meningitidis antigens and compositions |
| 09/17/2009 | US20090232817 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 09/17/2009 | US20090232816 Il-1 eta dna and polypeptides |
| 09/17/2009 | US20090232811 Bivalent, bispecific antibodies |
| 09/17/2009 | US20090232809 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/17/2009 | US20090232804 Humanized antibodies specific for von willebrand factor |
| 09/17/2009 | US20090232803 Antibodies to human il-1beta |
| 09/17/2009 | US20090232801 Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof |
| 09/17/2009 | US20090232797 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/17/2009 | US20090232795 1b20 pcsk9 antagonists |
| 09/17/2009 | US20090232788 Enzyme With Microbial Lysis Activity From Trichoderma Reesei |
| 09/17/2009 | US20090232783 Method for Regulating Production of Hemoglobin Beta Chains |
| 09/17/2009 | US20090232736 Dual specificity antibodies and methods of making and using |
| 09/17/2009 | US20090232734 Anti-tissue factor antibodies and compositions |
| 09/17/2009 | US20090232732 PRO108 Antibody Compositions and Methods of Use and Use of PRO108 to Assess Cancer Risk |
| 09/17/2009 | CA2718395A1 Cyclic compound and salt thereof |
| 09/17/2009 | CA2718394A1 Microorganism producing cyclic compound |
| 09/17/2009 | CA2717799A1 Expression of catalase in trichoderma |
| 09/17/2009 | CA2717340A1 Method of denaturing protein with enzymes |
| 09/17/2009 | CA2716801A1 Methods for identifying cells suitable for large-scale production of recombinant proteins |
| 09/16/2009 | EP2100968A1 Method of producing recombinant TAT-HOXB4H protein for use as a stimulant of hematopoiesis in vivo |
| 09/16/2009 | EP2100959A2 Mammalian cytokine: interleukin-B30 and related reagents |
| 09/16/2009 | EP2100955A2 Attenuated mutants of human parainfluenza virus type 1 (HPIV1) |
| 09/16/2009 | EP2099903A2 Modified polymerases and attenuated viruses and methods of use thereof |
| 09/16/2009 | EP2099899A1 Conditioning biomass for microbial growth |
| 09/16/2009 | EP2099825A2 Recombinant antibodies against hepatitis c virus and methods of obtaining and using same |
| 09/16/2009 | EP2099414A2 Human antibodies that bind human il-12 and methods for producing |
| 09/16/2009 | EP1904641B1 Process for the manufacture of eptifibatide |
| 09/16/2009 | EP1661909B1 Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 09/16/2009 | EP1449923B1 Novel formate dehydrogenase tolerant to halogen compounds and process for producing the same |
| 09/16/2009 | EP1414948B1 Inhibition of apoptosis process and improvement of cell performance |
| 09/16/2009 | EP1408050B1 A method of producing glucagon-like peptide 1(glp-1)7-36 and an glp-1 analogue |
| 09/16/2009 | EP1377608B1 Insulin precursors and a process for their preparation |
| 09/16/2009 | EP1126878B1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 09/16/2009 | EP1100815B1 Protease susceptibility ii |
| 09/16/2009 | EP1002084B1 Mammalian cytokine: interleukin-b30 and related reagents |
| 09/16/2009 | EP0966541B1 Method and constructs for inhibiting protein expression in bacteria |
| 09/16/2009 | CN101535494A Peptides containing tryptophan |
| 09/16/2009 | CN101535493A High-cell density fed-batch fermentation process for producing recombinant protein |
| 09/16/2009 | CN101535492A Method of expressing proteins with disulfide bridges |
| 09/16/2009 | CN101533024A Application of Yersinia pestis Caf1M protein |
| 09/16/2009 | CN101532046A Site-specific incorporation of redox active amino acids into proteins |
| 09/16/2009 | CN101532044A Method for preparing sea cucumber collagen small peptide freeze drying powder extracted from sea cucumber decoction liquor |
| 09/16/2009 | CN101532030A Recombinant influenza virus vector carrying foreign genes in NA segment and preparation method and application thereof |
| 09/16/2009 | CN101532016A A section of DNA molecule, recombination expression vector containing the DNA molecule and use thereof |
| 09/16/2009 | CN101532009A Preparation, identification and application of HA tag monoclonal antibody |
| 09/16/2009 | CN101532008A Preparation of anti beta-catenin monoclonal antibody and application thereof in pathologic examination of colon cancer |
| 09/16/2009 | CN101531967A Method for producing alpha interferon and dedicated bacteria therefor |
| 09/16/2009 | CN101531718A Anti-VEGFR-2 antibody chimeric Fab antibody fragment, preparation method and application thereof |
| 09/16/2009 | CN101531715A Cytokine protein family |
| 09/16/2009 | CN101531710A rF1 antigen, preparation method and application thereof |
| 09/16/2009 | CN101531700A Maize oligopeptide and method for preparing same |
| 09/15/2009 | US7589181 Humanized anti-TAG-72 CC49 monoclonal antibodies; retain binding affinity for TAG-72 and have reduced immunogenicity, as compared to a parental HuCC49V10 antibody; carcinoma; antitumor agent |
| 09/15/2009 | US7589180 Specific binding proteins and uses thereof |
| 09/15/2009 | US7589179 Modified interleukin-7 (IL-7) polypeptides with reduced T-cell response |
| 09/15/2009 | US7588929 Improved bacteriophage compositions comprising specific sugars that reduce or abolish the bacterial phage-neutralizing activity; used to treat infectious diseases |
| 09/15/2009 | US7588920 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| 09/15/2009 | US7588919 Polynucleotide encoding an IL-28B polypeptide |
| 09/15/2009 | US7588918 Mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity |
| 09/15/2009 | US7588917 Nucleic acids encoding sugar transport proteins and methods of using same |
| 09/15/2009 | US7588915 Isolated genomic polynucleotide fragments from chromosome 7 |
| 09/15/2009 | US7588885 Using amantadine to control translation of infectious enterovirus (EV) or encephalomyocarditis virus (EMCV); viricides |
| 09/15/2009 | US7588773 vaccines; use for detecting a group B streptococcus serotype III, RDP III-3 strain; drug screen an agent for inhibiting adhesion of a group B streptococcal cell to a host cell |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/15/2009 | US7588758 A genetic vector comprising a promoter linked to an expression cassette able to express a cyclooxygenase protein; treating bone disorder osteoporosis, heterotopic ossification |
| 09/15/2009 | US7588755 Immunomodulation by administration of a recombinant polypeptide produced by a non-human host transformed by a recombinant DNA molecule ; antiviral and antitumor or anticancer agents |
| 09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 09/15/2009 | CA2032158C Multivalent repressor of gene function |
| 09/11/2009 | WO2009111599A2 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/11/2009 | WO2009111086A1 Transgenic non-human mammals with kappa light chain of xenogenous immunoglobulin |
| 09/11/2009 | WO2009109129A1 A new type of consensus interferon and preparation method thereof |
| 09/11/2009 | WO2009086132A3 Design of spacers to increase the expression of recombinant fusion proteins |
| 09/11/2009 | WO2008082726A3 Real time monitoring of microbial enzymatic pathways |
| 09/11/2009 | WO2004039952A3 Methods of use for novel human polypeptides encoded by polynucleotides |
| 09/10/2009 | US20090229016 Cambium/xylem-preferred promoters and uses thereof |
| 09/10/2009 | US20090228997 Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereof |
| 09/10/2009 | US20090228994 Antibody Composition-Producing Cell |